Population-Level Death Rates From Novel Coronavirus (COVID-19) in South Korea

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

No abstract available

Article activity feed

  1. SciScore for 10.1101/2020.03.23.20041814: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    NIH rigor criteria are not applicable to paper type.

    Table 2: Resources

    No key resources detected.


    Results from OddPub: Thank you for sharing your data.


    Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:
    We note several limitations. First, the case distribution and case fatality rates on which we base our results were current as of 22 March 2020. However, the pandemic in South Korea, including the case distribution and case fatality rates could change rapidly.2 Another outbreak could overwhelm the capacity of the healthcare system and, consequently, case fatality rates may increase as limited healthcare resources are unable to accommodate the increasing number of COVID-19 patients.18 Second, our results are specific to South Korea, which was studied as their governmental agencies provided the most robust and updated case distribution and case fatality rate data by age. As a result, the ASDR of COVID-19 in South Korea, a nation which has been lauded for its widespread screening and early treatment, may differ from those of other countries.19 Our publicly available software allows researchers and public health officials to input case distributions by age, case fatality rates by age, and total number of cases (either laboratory confirmed or alternative scenarios) to estimate the mortality burden of COVID-19 for other countries. Third, the number of laboratory-confirmed cases could be less than the true number of cases, although South Korea has tested more individuals per capita to date than any other country. If the true number of cases exceeds the reported number of cases, the estimated number of deaths will increase and, thus, we may conservatively estimate the population-leve...

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.